VDRM .014 closed DOWN 41%....got some. ONLY 10 MIL
Post# of 102254
Posted On: 12/06/2014 4:08:24 PM
VDRM .014 closed DOWN 41%....got some. ONLY 10 MILLION FLOAT!!!! I repeat only 10 million float. Was Trading at 51 cents in August. Company just founded in May of 2014 FRESH.
ViaDerma, Inc. is a biotechnology licensing company committed to bringing new products quickly to the pharmaceutical industry through innovative research & development. ViaDerma licenses products in fields of medicine ranging from infectious diseases to stem-cell therapy.
Pharmaceutical companies today are among the safer bets. In a down economy such as it has been the last few years, ...
VDRM TetraStem has shown success in laboratory trials and found to be 99 percent effective against all bacteria. ViaDerma believes the application of TetraStem can maximize the healing of diabetic wounds before they require amputation.
Proprietary and Trade Secret Mechanism of Action
ViaDerma's proprietary transdermal delivery system allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy.
The technology allows transfer of chemicals through the stratum corneum (outer layer of skin) with a diffusion constant which is 10,000 times higher than the diffusion constant which characterizes water movement through the stratum corneum.
This enables ViaDerma to pair almost any active ingredient with the technology and provide rapid transport of the medicine right to the site of action.
Pharmaceutical companies today are among the safer bets. In a down economy such as it has been the last few years, and have the most EXPLOSIVE runs ... COULD THIS RUN BACK TO 50 CENTS? With a 10 million float the answer is HELL YEAH.
READ the latest news...MUCH MORE TO COME.
http://finance.yahoo.com/news/viaderma-inc-le...43674.html
ViaDerma, Inc. is a biotechnology licensing company committed to bringing new products quickly to the pharmaceutical industry through innovative research & development. ViaDerma licenses products in fields of medicine ranging from infectious diseases to stem-cell therapy.
Pharmaceutical companies today are among the safer bets. In a down economy such as it has been the last few years, ...
VDRM TetraStem has shown success in laboratory trials and found to be 99 percent effective against all bacteria. ViaDerma believes the application of TetraStem can maximize the healing of diabetic wounds before they require amputation.
Proprietary and Trade Secret Mechanism of Action
ViaDerma's proprietary transdermal delivery system allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy.
The technology allows transfer of chemicals through the stratum corneum (outer layer of skin) with a diffusion constant which is 10,000 times higher than the diffusion constant which characterizes water movement through the stratum corneum.
This enables ViaDerma to pair almost any active ingredient with the technology and provide rapid transport of the medicine right to the site of action.
Pharmaceutical companies today are among the safer bets. In a down economy such as it has been the last few years, and have the most EXPLOSIVE runs ... COULD THIS RUN BACK TO 50 CENTS? With a 10 million float the answer is HELL YEAH.
READ the latest news...MUCH MORE TO COME.
http://finance.yahoo.com/news/viaderma-inc-le...43674.html
(0)
(0)Scroll down for more posts ▼